WFG Advisors’s Allergan plc AGN.PRA Stock Holding History

WFG Advisors’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2	Closed	-$2K	–	1760
2016 Q1	$2K	Hold	2	–	–	﹤0.01%	1370
2015 Q4	$2K	Hold	2	–	–	﹤0.01%	1408
2015 Q3	$2K	Buy	+2	New	+$2.09K	﹤0.01%	1451

Other funds holding AGN.PRA

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

WFG Advisors's AGN.PRA Position: Q2 2016 in Review

WFG Advisors sold out of Allergan plc (AGN.PRA) in Q2 2016, closing a stake of 2 shares — an estimated $2K sold.

WFG Advisors first reported a position in AGN.PRA in Q3 2015 and held it in 3 quarters. The position peaked at $2K in Q1 2016. 108 funds tracked by Wall St. Rank hold AGN.PRA as of Q2 2016.

WFG Advisors reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
WFG Advisors sold 2 Allergan plc shares in Q2 2016, an estimated $2K.
WFG Advisors first reported a position in Allergan plc in Q3 2015 and held it in 3 quarters.
WFG Advisors's Allergan plc position peaked at $2K in Q1 2016.
108 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on WFG Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.